Novo Nordisk Rises, Centrica Gains, Inditex Up
On this episode of Stock Movers: - Novo Nordisk received an upgrade to buy from hold at Berenberg, which switches its preferences within the obesity sector to make the Danish company its top pick instead of Eli Lilly. - Morgan Stanley upgraded Centrica's stock to an overweight, or buy, rating. Their analyst made Centrica the new top pick within UK utilities. The shares aren’t even fully valuing its existing business, let alone potential upside from deals including Sizewell C and the Grain LNG terminal, a note said. - Inditex gained to outperform peers as UBS raised the recommendation on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.